MyFinsight
Home
About
Contact
stok: the income statement
Download
Download image
Unrealized gain on
marketable securities
$350K
(93.37%↑ Y/Y)
Comprehensive income (loss)
-$37,997K
(-44.76%↓ Y/Y)
Total other
comprehensive gain
$350K
(93.37%↑ Y/Y)
Net income (loss)
-$38,347K
(-45.09%↓ Y/Y)
Provision for income taxes
-$1,278K
Other income
(expense), net
$3K
(-89.29%↓ Y/Y)
Interest income
(expense), net
$3,463K
(-2.31%↓ Y/Y)
Income (loss) before
income taxes
-$39,625K
Total other income
(expense)
$3,466K
(-2.99%↓ Y/Y)
Income (loss) from
operations
-$43,091K
(-43.62%↓ Y/Y)
Revenue
$10,632K
(117.25%↑ Y/Y)
Total operating
expenses
$53,723K
(53.95%↑ Y/Y)
Sales, general and
administrative
$16,027K
Research and development
$37,696K
(69.76%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK)